3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
2
Vulvar Neoplasms
1
Sertoli-Leydig Cell Tumor
1
Ovarian gynandroblastoma
1
Granulosa cell tumor of the ovary
1
Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation
1
Endometrial Clear Cell Adenocarcinoma
1
Anus Neoplasms
1
Anal Canal Carcinoma
1
Interventions
dehydroftorafur
1
Taxes
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Platinum
1
Paclitaxel
1
Immune Checkpoint Inhibitors
1
Fluorouracil
1
Cisplatin
1
Chemoradiotherapy
1
Carboplatin
1
Capecitabine
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Anal Canal Carcinoma
×
1,2-diaminocyclohexaneplatinum II citrate
×
Clear all
NCT02560298
2023-06-22
InterAACT
Eastern Cooperative Oncology Group
Phase 2
Unknown
91 enrolled